[HTML][HTML] Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review
Z Zhang, S Yang, Y Ma, H Zhou, X Wu… - Translational Lung …, 2021 - ncbi.nlm.nih.gov
Background To systematically assess the consistency of recommendations regarding
diagnosis and treatment of non-small cell lung cancer (NSCLC) in clinical practice …
diagnosis and treatment of non-small cell lung cancer (NSCLC) in clinical practice …
[HTML][HTML] Death anxiety in patients with metastatic non-small cell lung cancer with and without brain metastases
AC Eggen, AKL Reyners, G Shen, I Bosma… - Journal of Pain and …, 2020 - Elsevier
Context Death anxiety is common in patients with metastatic cancer, but its relationship to
brain metastases and cognitive decline is unknown. Early identification of death anxiety and …
brain metastases and cognitive decline is unknown. Early identification of death anxiety and …
E2F1-mediated repression of WNT5A expression promotes brain metastasis dependent on the ERK1/2 pathway in EGFR-mutant non-small cell lung cancer
H Li, F Tong, R Meng, L Peng, J Wang, R Zhang… - Cellular and Molecular …, 2021 - Springer
Brain metastasis (BM) is associated with poor prognosis in patients with advanced non-
small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) mutation …
small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) mutation …
Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion …
Abstract Background The American Radium Society (ARS) Central Nervous System (CNS)
committee reviewed literature on epidermal growth factor receptor mutated (EGFRm) and …
committee reviewed literature on epidermal growth factor receptor mutated (EGFRm) and …
Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data
L Gutiérrez, A Royuela, E Carcereny, R López-Castro… - BMC cancer, 2021 - Springer
Background There is a lack of useful diagnostic tools to identify EGFR mutated NSCLC
patients with long-term survival. This study develops a prognostic model using real world …
patients with long-term survival. This study develops a prognostic model using real world …
[HTML][HTML] Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist
Y Yang, J Lu, Y Ma, C Xi, J Kang, Q Zhang… - Translational Lung …, 2021 - ncbi.nlm.nih.gov
Background In recent years, the number of clinical practice guidelines (CPGs) for lung
cancer has increased, but the quality of these guidelines has not been systematically …
cancer has increased, but the quality of these guidelines has not been systematically …
Treatment patterns and survival outcomes of non-small cell lung cancer patients initially diagnosed with brain metastases in real-world clinical practice
XR Chen, X Hou, XX Dinglin, YD Liu, Y Li… - Frontiers in …, 2020 - frontiersin.org
Background This study aimed to comprehensively analyze the characteristics, treatment
patterns, and survival outcomes of non-small-cell lung cancer (NSCLC) patients initially …
patterns, and survival outcomes of non-small-cell lung cancer (NSCLC) patients initially …
Prognostic value of cell-free DNA in cerebrospinal fluid from lung cancer patients with brain metastases during radiotherapy
S Qiao, Y Hao, L Cai, X Duan, L Wang, A Zhou… - Radiation Oncology, 2023 - Springer
Background During the last decades, radiotherapy (RT) for non-small cell lung cancer
(NSCLC) with brain metastases (BM) has been developed. However, the lack of predictive …
(NSCLC) with brain metastases (BM) has been developed. However, the lack of predictive …
Integrating supportive and palliative care into treatment of immunotherapy-sensitive cancers: from diagnosis to long-term survival or death
AC Eggen - 2022 - research.rug.nl
The introduction of targeted therapies and immunotherapy has greatly improved the
prognosis of various advanced cancers. Nowadays, immunotherapy is standard of care for …
prognosis of various advanced cancers. Nowadays, immunotherapy is standard of care for …